Butin inhibits osteoarthritis progression by modulating the Nrf2/HO-1 signaling pathway and inhibiting NF-κB signaling

Ping Zhou, Jun Chang, Xiaofei Wei, Chengxin Zhu, Junjun Yang, Chao Wang, Yong Hu, Chi Zhang · 2025

Read Butin inhibits osteoarthritis progression by modulating the Nrf2/HO-1 signaling pathway and inhibiting NF-κB signaling by Ping Zhou, Jun Chang, Xiaofei Wei, Chengxin Zhu, Junjun Yang, Chao Wang, Yong Hu, Chi Zhang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12753770.txt.

Description

Ping Zhou and co-authors test a plant flavonoid called butin against osteoarthritis in a 2025 study. Today's arthritis care mostly eases pain with anti-inflammatory drugs, and no safe drug yet slows the disease itself. Butin is known for calming inflammation and oxidation, but how it protects cartilage was unclear.

In lab tests, joint cells provoked with an inflammatory signal stayed healthier with butin present. The compound switched on the cell's antioxidant defense axis, raising protective proteins, while damping the inflammatory pathway that drives cartilage breakdown. It also preserved the cartilage matrix proteins that enzymes chew away in arthritis. Together the results draw a clear mechanism: butin defends cartilage on two fronts at once, which makes it a plausible candidate for a disease-slowing arthritis drug.

Catalog record

CREATORPing Zhou, Jun Chang, Xiaofei Wei, Chengxin Zhu, Junjun Yang, Chao Wang, Yong Hu, Chi Zhang
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12753770

Browse the full library · About the Tower of Babel